Detalhe da pesquisa
1.
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.
Oncologist
; 29(1): e118-e130, 2024 Jan 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37603442
2.
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.
Oncologist
; 2024 Mar 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38520745
3.
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
J Transl Med
; 22(1): 242, 2024 Mar 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38443899
4.
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(18): 1711-1723, 2020 10 29.
Artigo
Inglês
| MEDLINE | ID: mdl-32955177
5.
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
Br J Cancer
; 127(3): 383-393, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35264788
6.
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Br J Cancer
; 127(11): 2034-2042, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36175621
7.
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome.
Oncologist
; 27(2): e199-e202, 2022 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35641202
8.
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.
Oncologist
; 27(6): e484-e493, 2022 06 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35429394
9.
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.
Oncologist
; 27(2): 87-e115, 2022 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35641222
10.
Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification.
Cytokine
; 146: 155622, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34153874
11.
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.
Future Oncol
; 17(19): 2513-2527, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33988036
12.
A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer.
Future Oncol
; 17(35): 4827-4835, 2021 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34723634
13.
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer.
Br J Cancer
; 123(1): 81-91, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32376889
14.
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
Oncologist
; 25(12): e1996-e2005, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32557976
15.
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment.
Int J Mol Sci
; 21(5)2020 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32111093
16.
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors.
Oncologist
; 24(8): 1128-1136, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31015312
17.
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).
Oncologist
; 24(6): e318-e326, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30846513
18.
Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections?
World J Surg
; 43(5): 1385-1392, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30659342
19.
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer.
Int J Mol Sci
; 20(8)2019 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-30995715
20.
Detection of Loss of Heterozygosity in cfDNA of Advanced EGFR- or KRAS-Mutated Non-Small-Cell Lung Cancer Patients.
Int J Mol Sci
; 21(1)2019 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31861832